You are here

antivirals

US biotech uses AI to pick antiviral for COVID-19 trial

Pharmaforum

Mon, 07/27/20 - 11:10 pm

AI Therapeutics

artificial intelligence

clinical trials

Glenmark Pharmaceutical’s Antiviral Drug Hits the Mark in Small, Phase III COVID-19 Study

BioSpace

Thu, 07/23/20 - 07:13 pm

clinical trials

Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment

Pharmaceutical Business Review

Mon, 07/20/20 - 12:03 pm

clinical trials

Boehringer Ingelheim-backed COVID researchers identify new antibodies to fight the virus

Fierce Pharma

Fri, 07/10/20 - 10:58 am

Boehringer Ingelheim

5 FDA-approved antivirals could target COVID-19: study

Fierce Biotech

Thu, 07/2/20 - 12:07 am

Large UK study finds no benefit to HIV antiviral in COVID-19

BioPharma Dive

Tue, 06/30/20 - 11:31 pm

Atea raises $215M to support midphase COVID-19 antiviral trial

Fierce Biotech

Wed, 05/20/20 - 10:30 am

Atea Pharmaceuticals

clinical trials

Biosig cleared to test merimepodib plus remdesivir in COVID-19

Pharmaforum

Wed, 05/20/20 - 10:28 am

BioSig Technologies

clinical trials

Gilead’s Antiviral Remdesivir Had A Good Day - But It’s Still Not Clear How Effective It Is Against COVID-19

Forbes

Wed, 04/29/20 - 10:58 pm

Gilead Sciences

clinical trials

Gilead Antiviral Drug Shows the Most Potential for COVID-19, Says WHO Official

Motley Fool

Tue, 02/25/20 - 12:06 am

Gilead Sciences

Johnson & Johnson Expands Pact With U.S. Government to Seek a Treatment for COVID-19

Motley Fool

Tue, 02/18/20 - 08:37 pm

How will coronavirus hit U.S. drugmakers? Depends what kind of drugmaker you are

Fierce Pharma

Thu, 02/13/20 - 11:21 pm

How influenza discoveries could inspire a universal vaccine and new treatments

Fierce Biotech

Fri, 10/25/19 - 10:40 pm

drug development

Novartis licenses out early antiviral work to Gilead

Fierce Biotech

Fri, 07/19/19 - 10:51 am

Gilead Sciences

J&J stalls development of antiviral from Alios deal

BioCentury

Tue, 10/16/18 - 08:29 pm

Alios BioPharma

Roche’s antiviral hits flu targets in PhIII trial

Pharma Times

Tue, 07/17/18 - 10:06 am

baloxavir marboxil

Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs

Endpoints

Wed, 07/11/18 - 10:57 pm

Teva rolls out exclusive generic of Gilead's Viread at the end of an awful week

Fierce Pharma

Fri, 12/15/17 - 11:40 pm

Teva Pharmaceutical

Gilead Sciences

Merck says its antiviral medicine met late-stage primary endpoint

Marketwatch

Wed, 10/19/16 - 10:48 am

clinical trials

stem cell transplant

Chimerix scraps two PhIII trials as it regroups in wake of a setback

Fierce Biotech

Mon, 02/22/16 - 10:09 am

clinical trials

Pages